BIIB — BIOGEN INC

Ownership history in Pendal Group Ltd  ·  21 quarters on record

This page tracks every 13F SEC filing in which Pendal Group Ltd reported a position in BIOGEN INC (BIIB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.32% (2019 Q2)
Avg. % of fund
0.14%
First filed
2017 Q2
Last filed
2022 Q3
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2022 Q3 ADDED 13,914 +9,429 +210.2% 0.04% $3.7M $267.00
2022 Q2 REDUCED 4,485 -2,668 -37.3% 0.01% $915K $203.94
2022 Q1 ADDED 7,153 +4,111 +135.1% 0.01% $1.5M $210.60
2021 Q4 ADDED 3,042 +1,608 +112.1% 0.01% $730K $239.92
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BIIB price (monthly, adj. close)

Other funds also holding BIIB

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 4.5% BRIDGER MANAGEMENT, LLC 3Y 7Y 4.08% Patient Capital Management, LLC 3Y 3.92% SECTOR GAMMA AS 3Y 7Y 3.43% Hillman Capital Management, Inc. 3Y 7Y 3.38% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 3.22% Privium Fund Management B.V. 3Y 2.38% Logos Global Management LP 3Y 2.13% Orion Investment Co 2.11% PRIMECAP MANAGEMENT CO/CA/ 3Y 7Y 1.97%
← Back to Pendal Group Ltd Holdings